Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction

Study Questions:

Do extreme lipoprotein(a) [Lp(a)] levels and/or corresponding Lp(a) risk genotypes improve myocardial infarction (MI) and coronary heart disease (CHD) risk prediction beyond conventional risk factors?